9539

0

SAKAR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SAKAR HEALTHCARE LIMITED Share Price Today

SAKAR HEALTHCARE LIMITED is currently trading at ₹823.95, up by ₹20.35 from the previous close. The stock touched an intraday high of ₹828.05 and a low of ₹802.05 during the latest trading session. Over the past one year, SAKAR HEALTHCARE LIMITED has delivered a return of 126.78%, while the stock has gained 4.79% in the last one month.

SAKAR HEALTHCARE LIMITED performance

Today’s low Today’s high
₹ 802.05 ₹ 828.05
₹ 819.70
52 week low 52 week high
₹ 311.00 ₹ 889.95
₹ 819.70
Open Price ₹ 805.00
Prev. Close ₹ 803.60
Volume (Shares) 68690.00
Total traded value ₹ 563.05
Upper Circuit ₹ 883.95
Lower Circuit ₹ 723.25
info

Investment Returns

Over 1 Month 4.79% Over 3 Months 53.28% Over 6 Months 89.06% Over 1 Year 126.78%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SAKAR HEALTHCARE LIMITED fundamentals


  • Market cap (Cr) 1,829.50
  • P/E Ratio (TTM) 58.66
  • Beta 0.67
  • Book Value / share 145.86
  • Return on equity 6.39%
  • EPS (TTM) 13.70
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 11.02
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

SAKAR HEALTHCARE LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 71.10
Operating Expense 53.20
Net Profit 11.02
Net Profit Margin (%) 15.49
Earnings Per Share (EPS) 4.96
EBITDA 26.41
Effective Tax Rate (%) 38.98
Particulars DEC 2025 (Values in Cr)
Revenue 70.34
Operating Expense 59.90
Net Profit 10.25
Net Profit Margin (%) 14.57
Earnings Per Share (EPS) 4.59
EBITDA 19.09
Effective Tax Rate (%) 6.39
Particulars SEP 2025 (Values in Cr)
Revenue 57.56
Operating Expense 53.42
Net Profit 4.54
Net Profit Margin (%) 7.88
Earnings Per Share (EPS) 2.03
EBITDA 12.57
Effective Tax Rate (%) 15.29
Particulars JUN 2025 (Values in Cr)
Revenue 52.74
Operating Expense 47.74
Net Profit 4.67
Net Profit Margin (%) 8.85
Earnings Per Share (EPS) 2.11
EBITDA 13.09
Effective Tax Rate (%) 13.19
Particulars MAR 2025 (Values in Cr)
Revenue 50.24
Operating Expense 44.18
Net Profit 5.76
Net Profit Margin (%) 11.46
Earnings Per Share (EPS) 2.66
EBITDA 15.91
Effective Tax Rate (%) 7.69
Particulars MAR 2026 (Values in Cr)
Revenue 251.74
Operating Expense 214.27
Net Profit 30.48
Net Profit Margin (%) 12.10
Earnings Per Share (EPS) 13.70
EBITDA 71.17
Effective Tax Rate (%) 23.31
Particulars MAR 2025 (Values in Cr)
Revenue 177.58
Operating Expense 157.32
Net Profit 17.50
Net Profit Margin (%) 9.85
Earnings Per Share (EPS) 7.97
EBITDA 50.95
Effective Tax Rate (%) 18.71
Particulars MAR 2024 (Values in Cr)
Revenue 153.35
Operating Expense 140.63
Net Profit 11.67
Net Profit Margin (%) 7.61
Earnings Per Share (EPS) 5.64
EBITDA 41.54
Effective Tax Rate (%) 26.60
Particulars MAR 2023 (Values in Cr)
Revenue 133.36
Operating Expense 121.15
Net Profit 12.76
Net Profit Margin (%) 9.56
Earnings Per Share (EPS) 6.58
EBITDA 37.82
Effective Tax Rate (%) 24.40
Particulars MAR 2022 (Values in Cr)
Revenue 128.23
Operating Expense 111.39
Net Profit 15.24
Net Profit Margin (%) 11.88
Earnings Per Share (EPS) 8.77
EBITDA 31.58
Effective Tax Rate (%) 19.83
Particulars MAR 2025 (Values in Cr)
Book Value / Share 128.75
ROE % 6.39
ROCE % 8.37
Total Debt to Total Equity 0.30
EBITDA Margin 28.69
Particulars MAR 2024 (Values in Cr)
Book Value / Share 118.41
ROE % 5.36
ROCE % 7.36
Total Debt to Total Equity 0.46
EBITDA Margin 27.09
Particulars MAR 2023 (Values in Cr)
Book Value / Share 91.04
ROE % 8.48
ROCE % 8.85
Total Debt to Total Equity 0.70
EBITDA Margin 28.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 74.45
ROE % 13.49
ROCE % 12.05
Total Debt to Total Equity 0.60
EBITDA Margin 24.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 63.04
ROE % 11.88
ROCE % 13.07
Total Debt to Total Equity 0.33
EBITDA Margin 25.09
Particulars MAR 2025 (Values in Cr)
Book Value / Share 128.78
ROE % 6.39
ROCE % 8.37
Total Debt to Total Equity 0.30
EBITDA Margin 28.69
Particulars MAR 2024 (Values in Cr)
Book Value / Share 118.44
ROE % 5.36
ROCE % 7.36
Total Debt to Total Equity 0.46
EBITDA Margin 27.09
Particulars MAR 2023 (Values in Cr)
Book Value / Share 91.09
ROE % 8.48
ROCE % 8.85
Total Debt to Total Equity 0.70
EBITDA Margin 28.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 74.50
ROE % 13.49
ROCE % 12.05
Total Debt to Total Equity 0.60
EBITDA Margin 24.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 63.04
ROE % 11.89
ROCE % 13.07
Total Debt to Total Equity 0.33
EBITDA Margin 25.10
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 415.26
Total Liabilities 415.26
Total Equity 285.47
Share Outstanding 2
Price to Book Ratio 1.64
Return on Assets (%) 4.21
Return on Capital (%) 4.86
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 388.65
Total Liabilities 388.65
Total Equity 262.33
Share Outstanding 2
Price to Book Ratio 3.11
Return on Assets (%) 3.00
Return on Capital (%) 3.52
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 336.33
Total Liabilities 336.33
Total Equity 173.34
Share Outstanding 1
Price to Book Ratio 2.20
Return on Assets (%) 3.79
Return on Capital (%) 4.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 267.76
Total Liabilities 267.76
Total Equity 127.46
Share Outstanding 1
Price to Book Ratio 1.81
Return on Assets (%) 5.66
Return on Capital (%) 7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 177.79
Total Liabilities 177.79
Total Equity 98.45
Share Outstanding 1
Price to Book Ratio 1.79
Return on Assets (%) 6.00
Return on Capital (%) 7.71
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 415.34
Total Liabilities 415.34
Total Equity 285.56
Share Outstanding 2
Price to Book Ratio 1.64
Return on Assets (%) 4.21
Return on Capital (%) 4.85
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 388.74
Total Liabilities 388.74
Total Equity 262.41
Share Outstanding 2
Price to Book Ratio 3.11
Return on Assets (%) 3.00
Return on Capital (%) 3.52
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 336.42
Total Liabilities 336.42
Total Equity 173.43
Share Outstanding 1
Price to Book Ratio 2.20
Return on Assets (%) 3.79
Return on Capital (%) 4.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 267.84
Total Liabilities 267.84
Total Equity 127.53
Share Outstanding 1
Price to Book Ratio 1.81
Return on Assets (%) 5.69
Return on Capital (%) 7.02
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 177.80
Total Liabilities 177.80
Total Equity 98.46
Share Outstanding 1
Price to Book Ratio 1.79
Return on Assets (%) 6.01
Return on Capital (%) 7.71
Particulars MAR 2025 (Values in Cr)
Net Income 21.52
Cash from Operations 36.40
Cash from Investing -30.70
Cash from Financing -3.47
Net change in Cash -0.15
Free Cash Flow 68.68
Particulars MAR 2024 (Values in Cr)
Net Income 15.89
Cash from Operations 27.61
Cash from Investing -51.53
Cash from Financing 27.44
Net change in Cash 0.37
Free Cash Flow 87.17
Particulars MAR 2023 (Values in Cr)
Net Income 16.87
Cash from Operations 37.60
Cash from Investing -74.37
Cash from Financing 41.09
Net change in Cash 0.06
Free Cash Flow 119.80
Particulars MAR 2022 (Values in Cr)
Net Income 19.00
Cash from Operations 35.52
Cash from Investing -90.37
Cash from Financing 54.62
Net change in Cash -0.05
Free Cash Flow 133.05
Particulars MAR 2021 (Values in Cr)
Net Income 13.23
Cash from Operations 15.30
Cash from Investing -46.83
Cash from Financing 32.03
Net change in Cash -0.22
Free Cash Flow 62.13
Particulars MAR 2025 (Values in Cr)
Net Income 21.52
Cash from Operations 36.40
Cash from Investing -30.70
Cash from Financing -3.47
Net change in Cash -0.15
Free Cash Flow 68.68
Particulars MAR 2024 (Values in Cr)
Net Income 15.89
Cash from Operations 27.61
Cash from Investing -51.53
Cash from Financing 27.44
Net change in Cash 0.37
Free Cash Flow 87.17
Particulars MAR 2023 (Values in Cr)
Net Income 16.87
Cash from Operations 37.60
Cash from Investing -74.37
Cash from Financing 41.09
Net change in Cash 0.06
Free Cash Flow 119.80
Particulars MAR 2022 (Values in Cr)
Net Income 19.00
Cash from Operations 35.59
Cash from Investing -90.40
Cash from Financing 54.56
Net change in Cash -0.05
Free Cash Flow 133.12
Particulars MAR 2021 (Values in Cr)
Net Income 13.24
Cash from Operations 15.31
Cash from Investing -46.83
Cash from Financing 32.03
Net change in Cash -0.21
Free Cash Flow 62.14
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.20 14.92 2.44 995.36 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTAJAN HEALTH LTD 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

SAKAR HEALTHCARE LIMITED shareholding pattern

Holding
22.87%
52.85%
12.94%
11.32%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

SAKAR HEALTHCARE LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
822.25 2.32 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 807.50
  • 26 Days 773.30
  • 10 Days 807.80
  • 50 Days 713.10
  • 12 Days 805.60
  • 100 Days 624.90
  • 20 Days 788.90
  • 200 Days 529.20
798.22 PIVOT
First Support 782.68 First Resistance 811.43 Second Support 769.47 Second Resistance 826.97 Third Support 753.93 Third Resistance 840.18
RSI 55.91 ADX 39.61 MACD 32.31 Williams % R -63.99 Commodity Channel Index (CCI) -23.89
Date 2026-06-19 Week 50795.00 Same Day 26176.00 Month 74457.00
1 Year 0.67 3 Year 0.79
Over 1 Month
4.79% down
Over 1 Year
126.78% down
Over 3 Months
53.28% down
Over 3 Years
46.56% down
Over 6 Months
89.06% down
Over 5 Years
40.63% down

SAKAR HEALTHCARE LIMITED Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sakar Healthcare Ltd?

Answer Field

Sakar Healthcare Ltd share price is for NSE ₹ 823.95 & for BSE ₹ 0.00 as on Jun 22 2026 02:05 PM.

What is the Market Cap of Sakar Healthcare Ltd Share?

Answer Field

The market cap of Sakar Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 22 2026 02:05 PM.

What is the 52 Week High and Low of Sakar Healthcare Ltd?

Answer Field

The 52 Week High and Low of Sakar Healthcare Ltd for NSE is ₹ 889.95 and ₹ 311.00 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Sakar Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 126.78%.

What is the P/E Ratio of Sakar Healthcare Ltd Share?

Answer Field

As on Jun 22 2026 02:05 PM the price-to-earnings (PE) ratio for Sakar Healthcare Ltd share is 58.66.

What is the PB ratio of Sakar Healthcare Ltd Share?

Answer Field

As on Jun 22 2026 02:05 PM, the price-to-book (PB) ratio for Sakar Healthcare Ltd share is 145.86.

How to Buy Sakar Healthcare Ltd Share?

Answer Field

You can trade in Sakar Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sakar Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Sakar Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sakar Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|